Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Local GAMP CoP
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Scholarships
    • Chapter Awards
      • NEW Chapter Awards 2024
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Local GAMP CoP
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Scholarships
    • Chapter Awards
      • NEW Chapter Awards 2024
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
Featured Image

Verve’s Cholesterol-Lowering Treatment Shows No Safety Issues in Trial

  • Posted by ISPE Boston
  • On May 1, 2025
Verve Therapeutics has won FDA clearance of its Investigational New Drug (IND) application for VERVE-102 for the treatment of patients with familial hypercholesterolemia (HeFH) and/or premature coronary artery disease (CAD). VERVE-102 is a novel, investigational in vivo base editing medicine designed to be a single-course treatment that inactivates the PCSK9 gene in the liver to durably lower blood low-density […]
Read More
 
Featured Image

Student Voices: Reflections on the 2025 ISPE Aseptic Conference

  • Posted by Ashutosh Anand
  • On April 24, 2025
The 2025 ISPE Aseptic Conference held March 17-18 in Washington, D.C., brought together professionals and students from across the pharmaceutical and biotech sectors to share insights, innovations, and challenges in aseptic manufacturing. Through the generous ISPE Student Grant program, three Northeastern University students—Afrah Mujeeb (MS Regulatory Affairs), Savani Nagarkar (MS Biotechnology), and Nazneen Khan (MS […]
Read More
 
Featured Image

Behind the Counter: What You Don’t See About Drug Prices – Featuring Vinay Patel on the Future of Pharma Podcast

  • Posted by ISPE Boston
  • On April 17, 2025
The ISPE Boston Area Chapter’s Future of Pharma Podcast continues to explore the cutting edge of life sciences and healthcare with conversations that push beyond the lab and into the systems that support patients every day. In Episode 32, we take a detour from the usual lineup of pharmaceutical industry leaders and turn our attention […]
Read More
 
Featured Image

Sionna Therapeutics Goes Public with $219 Million IPO

  • Posted by ISPE Boston
  • On April 10, 2025
Sionna Therapeutics, a Waltham biotech targeting cystic fibrosis, has closed its IPO, raising about $219 million. Sionna is a clinical-stage company seeking to revolutionize the current treatment paradigm for CF by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Sionna’s goal is to deliver differentiated medicines for […]
Read More
 
Featured Image

Chapter Member Anniversaries: April 2025

  • Posted by ISPE Boston
  • On April 4, 2025
Please congratulate the following members celebrating milestone anniversaries in April 2025.  Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Ryan Ark, Alnylam Pharmaceuticals Robert P. Barreira Rick E. Cavalli, Stellix Global Services Michael S. Cheney, Biogen Idec Donald Cole, Hart Passivation Services, Inc. Gregg A. Conboy, Erland […]
Read More
 
Featured Image

Welcome New Members March 2025

  • Posted by ISPE Boston
  • On April 4, 2025
We would like to introduce the Members who joined ISPE in March 2025, welcome them to the Chapter, and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]
Read More
 
Featured Image

Scholarship Application Now Open!

  • Posted by ISPE Boston
  • On April 3, 2025
​The ISPE Boston Area Chapter Scholarship Foundation is pleased to announce that applications for the Joel Goldenberg Memorial Scholarship and the Dan Rufo STEM Scholarship are now open. These scholarships aim to support students pursuing careers in pharmaceutical and biopharmaceutical manufacturing by providing financial assistance for their education. Application Period: Start Date: April 1, 2025​ End Date: June […]
Read More
 
Featured Image

FDA Approves Two Alnylam RNAi Therapies

  • Posted by ISPE Boston
  • On April 3, 2025
Alnylam delivered a one-two punch in March, growing its portfolio of FDA-approved RNAi therapies with the addition of Amvuttra (vutrisiran) for transthyretin amyloid cardiomyopathy (ATTR-CM) and Qfitlia (fitusiran) for hemophilia. Qfitlia (fitusiran) is the sixth Alnylam-discovered RNAi therapeutic approved in the U.S., and the first and only therapeutic to lower antithrombin (AT), a protein that inhibits blood clotting, and […]
Read More
 
Featured Image

Biogen to Open New Global Headquarters in Kendall Square

  • Posted by ISPE Boston
  • On March 26, 2025
Biogen has announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year real estate consolidation plan in Massachusetts. The move centralizes Biogen’s presence in Kendall Square, integrating Biogen’s R&D and technical operations teams alongside its global and North American commercial organizations into a co-located […]
Read More
 
Featured Image

Celebrating Excellence: Our Gala and Award Winners!

  • Posted by ISPE Boston
  • On March 24, 2025
We are beyond excited to share the incredible success of our recent Gala, a night dedicated to honoring the remarkable achievements of individuals and organizations that have truly gone above and beyond in their respective fields. The evening was filled with inspiration, celebration, and a sense of pride as we recognized the exceptional contributions that […]
Read More
 
Page 2 of 118‹1234›»
Post Categories
  • Podcasts (1)
  • Industry Buzz (559)
  • Chapter News (540)
  • Knowledge & Training (79)
  • Students & YP (78)
  • Career Tools (13)
Get Updates via Email




Scroll
Follow Us
Search this Site
@2024 ISPE Boston Chapter. All rights reserved.